Market Overview:
The global microalbumin test market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of diabetes and other renal disorders, growing awareness about early diagnosis and treatment of renal disorders, and technological advancements in microalbumin testing devices. Based on type, the global microalbumin test market is segmented into analyzers, reagent kits, control kits, micro-cuvettes, test strips, and others. The analyzers segment is expected to account for the largest share of the global market in 2018. This segment is also projected to grow at a CAGR of 7.8% during the forecast period from 2018 to 2030 due to its high adoption rate across hospitals and clinics worldwide.
Product Definition:
A microalbumin test is a blood test that measures the amount of albumin in your urine. Albumin is a protein that helps keep fluid in your blood vessels. A high level of albumin in your urine may mean you have kidney damage.
Analyzer:
An analyzer is a tool that helps to measure the concentration of a specific substance in Solution, Biological Fluids or Whole Body. It's major applications are in clinical laboratories and research institutes for measuring blood sugar levels, electrolytes, urea & creatinine level in urine and many other parameters. Analyzers are also used by pharmaceutical companies for quality control during drug manufacturing process.
Reagent Kit:
Reagent kit is used for testing the concentration of microalbumin in human serum, plasma or urine. The reagent also finds its application in other tests such as International Enzyme Immunodiagnosis (IEID) and Food Intolerance Test (FIT).
The demand for Reagent Kit.
Application Insights:
The others segment held the largest market share in 2017. This is attributed to the growing use of microalbumin tests for various purposes, such as drug discovery and development, clinical trials, food safety testing and quality control. Microalbumin tests are also used for pre-clinical drug toxicity testing. The clinical applications of these tests are expected to witness a CAGR of XX% from 2018 to 2030 owing to its increasing usage in diagnosis or exclusion of acute kidney injury (AKI) in patients undergoing any type of dialysis or nephrological procedures.
Microalbumin test finds wide application across different industries including healthcare & pharmaceuticals, food & beverage processing and manufacturing, water treatment plants etc.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of key players, high adoption rate of novel technologies, and increasing prevalence of chronic diseases such as cancer and diabetes. Moreover, rising government initiatives for quality healthcare are also expected to boost regional growth over the forecast period. Asia Pacific is expected to witness lucrative growth during the forecast period owing to factors such as improving healthcare infrastructure & availability of advanced products coupled with growing target population base in this region.
Moreover, a rise in foreign investments by international companies into emerging economies like India and China has led these nations being considered as hubs for technological advancements that would eventually influence future product development trends within this industry; hence driving demand across APAC region during estimated time frame (2018-2030).
Growth Factors:
- Increasing prevalence of diabetes and other renal diseases: The increasing prevalence of diabetes and other renal diseases is a major growth driver for the microalbumin test market. According to the World Health Organization, around 422 million people were living with diabetes in 2014, and this number is expected to reach 642 million by 2030. This will lead to an increase in the demand for microalbumin tests as these tests are used to diagnose and monitor diabetic nephropathy.
- Technological advancements: The development of new technologies that can improve the accuracy and speed of microalbumin tests is a major growth driver for this market. For instance, recent advances in immunoassay technology have led to the development of point-of-care (POC) devices that can provide rapid results within minutes. This has led to an increase in the use of POC devices for diagnosing renal disorders, which is driving demand for microalbumin tests.
- Growing awareness about early diagnosis and treatment: There is growing awareness among patients about the importance of early diagnosis and treatment for chronic kidney diseases (CKDs). This has led to an increase in demand for diagnostic tests such as microalbumin test, which can help detect CKDs at an early stage when they are still reversible .This is likely to drive growth prospects for the globalmicro albumin test market overthe forecast period .
Scope Of The Report
Report Attributes
Report Details
Report Title
Microalbumin Test Market Research Report
By Type
Analyzer, Reagent Kit, Control Kit, Micro-Cuvettes, Test Strips, Others
By Application
Hospitals, Clinics, Diagnostics Laboratories, Others
By Companies
Roche, Abbott, Danaher, Siemens, Nova Biomedical, ARKRAY, OPTI Medical, ACON Laboratories, Sysmex, 77 Elektronika, Randox Laboratories, URIT Medical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
236
Number of Tables & Figures
166
Customization Available
Yes, the report can be customized as per your need.
Global Microalbumin Test Market Report Segments:
The global Microalbumin Test market is segmented on the basis of:
Types
Analyzer, Reagent Kit, Control Kit, Micro-Cuvettes, Test Strips, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Diagnostics Laboratories, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Roche
- Abbott
- Danaher
- Siemens
- Nova Biomedical
- ARKRAY
- OPTI Medical
- ACON Laboratories
- Sysmex
- 77 Elektronika
- Randox Laboratories
- URIT Medical
Highlights of The Microalbumin Test Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Analyzer
- Reagent Kit
- Control Kit
- Micro-Cuvettes
- Test Strips
- Others
- By Application:
- Hospitals
- Clinics
- Diagnostics Laboratories
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Microalbumin Test Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Microalbumin test is a blood test that measures the level of microalbumin in your blood. Microalbumin is a protein found in the blood and it can be used to determine if you have liver or kidney problems.
Some of the key players operating in the microalbumin test market are Roche, Abbott, Danaher, Siemens, Nova Biomedical, ARKRAY, OPTI Medical, ACON Laboratories, Sysmex, 77 Elektronika, Randox Laboratories, URIT Medical.
The microalbumin test market is expected to grow at a compound annual growth rate of 7.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Microalbumin Test Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Microalbumin Test Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Microalbumin Test Market - Supply Chain
4.5. Global Microalbumin Test Market Forecast
4.5.1. Microalbumin Test Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Microalbumin Test Market Size (000 Units) and Y-o-Y Growth
4.5.3. Microalbumin Test Market Absolute $ Opportunity
5. Global Microalbumin Test Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Microalbumin Test Market Size and Volume Forecast by Type
5.3.1. Analyzer
5.3.2. Reagent Kit
5.3.3. Control Kit
5.3.4. Micro-Cuvettes
5.3.5. Test Strips
5.3.6. Others
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Microalbumin Test Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Microalbumin Test Market Size and Volume Forecast by Application
6.3.1. Hospitals
6.3.2. Clinics
6.3.3. Diagnostics Laboratories
6.3.4. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Microalbumin Test Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Microalbumin Test Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Microalbumin Test Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Microalbumin Test Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Microalbumin Test Demand Share Forecast, 2019-2026
9. North America Microalbumin Test Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Microalbumin Test Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Microalbumin Test Market Size and Volume Forecast by Application
9.4.1. Hospitals
9.4.2. Clinics
9.4.3. Diagnostics Laboratories
9.4.4. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Microalbumin Test Market Size and Volume Forecast by Type
9.7.1. Analyzer
9.7.2. Reagent Kit
9.7.3. Control Kit
9.7.4. Micro-Cuvettes
9.7.5. Test Strips
9.7.6. Others
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Microalbumin Test Demand Share Forecast, 2019-2026
10. Latin America Microalbumin Test Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Microalbumin Test Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Microalbumin Test Market Size and Volume Forecast by Application
10.4.1. Hospitals
10.4.2. Clinics
10.4.3. Diagnostics Laboratories
10.4.4. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Microalbumin Test Market Size and Volume Forecast by Type
10.7.1. Analyzer
10.7.2. Reagent Kit
10.7.3. Control Kit
10.7.4. Micro-Cuvettes
10.7.5. Test Strips
10.7.6. Others
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Microalbumin Test Demand Share Forecast, 2019-2026
11. Europe Microalbumin Test Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Microalbumin Test Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Microalbumin Test Market Size and Volume Forecast by Application
11.4.1. Hospitals
11.4.2. Clinics
11.4.3. Diagnostics Laboratories
11.4.4. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Microalbumin Test Market Size and Volume Forecast by Type
11.7.1. Analyzer
11.7.2. Reagent Kit
11.7.3. Control Kit
11.7.4. Micro-Cuvettes
11.7.5. Test Strips
11.7.6. Others
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Microalbumin Test Demand Share, 2019-2026
12. Asia Pacific Microalbumin Test Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Microalbumin Test Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Microalbumin Test Market Size and Volume Forecast by Application
12.4.1. Hospitals
12.4.2. Clinics
12.4.3. Diagnostics Laboratories
12.4.4. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Microalbumin Test Market Size and Volume Forecast by Type
12.7.1. Analyzer
12.7.2. Reagent Kit
12.7.3. Control Kit
12.7.4. Micro-Cuvettes
12.7.5. Test Strips
12.7.6. Others
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Microalbumin Test Demand Share, 2019-2026
13. Middle East & Africa Microalbumin Test Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Microalbumin Test Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Microalbumin Test Market Size and Volume Forecast by Application
13.4.1. Hospitals
13.4.2. Clinics
13.4.3. Diagnostics Laboratories
13.4.4. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Microalbumin Test Market Size and Volume Forecast by Type
13.7.1. Analyzer
13.7.2. Reagent Kit
13.7.3. Control Kit
13.7.4. Micro-Cuvettes
13.7.5. Test Strips
13.7.6. Others
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Microalbumin Test Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Microalbumin Test Market: Market Share Analysis
14.2. Microalbumin Test Distributors and Customers
14.3. Microalbumin Test Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Roche
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Abbott
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Danaher
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Siemens
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Nova Biomedical
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. ARKRAY
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. OPTI Medical
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. ACON Laboratories
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Sysmex
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. 77 Elektronika
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Randox Laboratories
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. URIT Medical
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
